corilagin has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HY; Huang, H; Ma, Y; Pang, K; Peng, Y; Shu, G; Wu, C; Yang, X; Zhou, T | 1 |
| Lin, Y; Liu, L; Qiu, F; Yang, Z | 1 |
2 other study(ies) available for corilagin and Esophageal Neoplasms
| Article | Year |
|---|---|
Anti-esophageal Cancer Effect of Corilagin Extracted from Phmllanthi Fructus via the Mitochondrial and Endoplasmic Reticulum Stress Pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Drugs, Chinese Herbal; Endoplasmic Reticulum Stress; Esophageal Neoplasms; Glucosides; Humans; Hydrolyzable Tannins; Mice, Nude; Mitochondria; Plant Extracts; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |
Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Count; Cell Proliferation; Cells, Cultured; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Glucosides; Humans; Hydrolyzable Tannins; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Structure-Activity Relationship; Ubiquitin-Protein Ligases | 2019 |